Benzinga
25 Jan 2026, 14:01 UTC · 33w ago
Verdict
Headline takes no side. We score AG +1.00 across four claims — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Moderna (MRNA) shares rose 17.44% following positive five-year follow-up results from a Phase 2b study of its melanoma vaccine in combination with Keytruda.
So whatSuccessful long-term clinical trial data for a cancer vaccine is a high-value catalyst for biotech valuation and pipeline viability.
More positive than 91% of claims this week
Venture Global (VG) saw a 21.6% jump after the ICC issued a final arbitration award denying Repsol's claims and ordering payment of fees.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 85% of claims this week
Precious metal stocks, including Hecla Mining and First Majestic Silver, rallied due to a weakening US dollar and expectations of Fed rate cuts.
More positive than 77% of claims this week
William Blair analyst Sebastien Naji initiated coverage on Micron Technology (MU) with an Outperform rating.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The stock increased 26.57% over the week.
More positive than 99% of ticker scores this week
The stock gained 29.31% due to rising precious metal prices.
More positive than 99% of ticker scores this week
The stock jumped 13.21% and received an Outperform rating from William Blair.
More positive than 99% of ticker scores this week
The stock jumped 21.6% following a favorable arbitration award.
More positive than 99% of ticker scores this week
The stock increased 23.13% over the week.
More positive than 99% of ticker scores this week
The stock gained 15.29% over the week.
More positive than 99% of ticker scores this week
The stock gained 24.03% over the week.
More positive than 99% of ticker scores this week
The stock jumped 13.82% over the week.
More positive than 99% of ticker scores this week
The stock rose 17.44% following positive cancer trial data.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
−26.1%
Price is moving against the score
$18.80 vs $25.44 close before publication (Jan 23) · not market-adjusted
AG chart →
